期刊文献+

血清降钙素原检测对革兰阴性菌或革兰阳性菌血流感染的诊断价值 被引量:16

Diagnostic Value of Serum Procalcitonin Measurement for Identification of Gram-negative and Gram-positive Bacterial Bloodstream Infections
原文传递
导出
摘要 目的探讨血清降钙素原(PCT)水平对鉴别革兰阴性(G-)菌与革兰阳性(G+)菌血流感染的临床价值。方法回顾性分析从2012年1月至2013年5月入院的血流感染患者,所有患者血培养为单一菌株且检测了血清PCT水平,同期血培养阴性的局部感染患者47例为对照组。比较PCT水平在G-菌、G+菌血流感染患者之间的差异,同时根据受试者工作特征(ROC)曲线判断PCT的诊断效能。结果纳入血流感染患者166例,其中G-菌感染109例,G+菌感染57例。G-菌组、G+菌组和对照组PCT水平中位数分别为12.72 ng/mL、2.50 ng/mL和0.22 ng/mL,各组间PCT水平差异有统计学意义(P<0.05)。根据ROC曲线,当PCT界值设定为4.82 ng/mL时,血清PCT水平区分G-与G+菌所致血流感染的灵敏度为80.0%,特异度为74.7%。结论血清PCT水平检测对鉴别G-菌与G+菌引起的血流感染患者有一定的临床应用价值。当PCT>4.82 ng/mL时,G-菌感染可能性大。 Objective To investigate the clinical value of serum procalcitonin (PCT) levels for differentiating Gram-negative ( G- ) and Gram-positive ( G + ) bacterial bloodstream infections. Methods The clinical data of 166 patients with bloodstream infections admitted between January 2012 and May 2013 who had a single strain infection in blood culture and PCT levels results were analyzed retrospectively. Meanwhile patients with local infection with negative blood cultures were recruited as control. The serum PCT levels were compared between the patients with G- and G + bacteria bloodstream infection. The cut-off value of PCT was determined by receiver operating characteristic (ROC) curve analysis. Results In 166 patients with bloodstream infections, 109 cases were infected with G- bacteria,57 cases with G+ bacteria Median levels of PCT were 12. 72 ng/mL,2. 50 ng/mL, and O. 22 ng/mL in the G- bacteria infection group, the G + bacteria infection group, and the control group, respectively, with significant difference among three groups. According to ROC curve, PCT level at 4. 82 ng/mL could distinguish G - bacteria infection from G + bacteria infection with a sensitivity of 80. 0% and a specificity of 74. 7%. Conclusions Serum PCT has diagnostic value in differentiating G- and G+ bacteria bloodstream infections. The risk of G- bacteria bloodstream infection is increased when PCT is 〉 4. 82 ng/mL.
出处 《中国呼吸与危重监护杂志》 CAS 2014年第4期374-377,共4页 Chinese Journal of Respiratory and Critical Care Medicine
关键词 降钙素原 革兰阴性菌 革兰阳性菌 血流感染 Procalcitonin Gram-negative bacteria Gram-positive bacteria Bloodstreaminfection
  • 相关文献

参考文献21

  • 1Schroeder S, Hochreiter M, Koehler T, et al. Procalcitonin ( PCT ) - guided algorithm reduces length of antibiotic treatment in surgical intensive care patients with severe sepsis: results of a prospective randomized study. Langenbecks Arch Surg,2009,394:221-226.
  • 2蒋贤高,汪晓波,王仁数.脓毒血症患者监测血清降钙素原、C反应蛋白的临床意义[J].中国呼吸与危重监护杂志,2009,8(5):429-431. 被引量:62
  • 3Previsdomini M, Gini M, Cerutti B, et al. Predictors of positive blood cultures in critically ill patients: a retrospective evaluation. Croat Med J,2012,53:30-39.
  • 4Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria. BMC Infect Dis, 2008,8 : 38.
  • 5Uckay I, Garzoni C, Ferry T, et al. Postoperative serum pro- ealcitonin and C-reactive protein levels in patients with orthopedic infections. Swiss Med Wkly,2010,140 :w13124.
  • 6刘慧琳,刘桂花,马青变.降钙素原对急诊脓毒症患者早期诊断的价值[J].中国危重病急救医学,2012,24(5):298-301. 被引量:150
  • 7Uzzan B, Cohen R, Nicolas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med ,2006,34 : 1996- 2003.
  • 8黄伟平,江稳强,胡北,叶珩,曾红科.降钙素原对全身炎症反应综合征患者病情预后的判断价值[J].中国危重病急救医学,2012,24(5):294-297. 被引量:110
  • 9邢豫宾,戴路明,赵芝焕,李志伟,李超.血清降钙素原和常用炎症指标结合SOFA评分对脓毒症早期诊断和预后价值的评价[J].中国危重病急救医学,2008,20(1):23-28. 被引量:123
  • 10Haaspera C, Kalmbach M, Dikos D, et al. Prognostic value of procalcitonin(PCT) and/or interleukin-6(IL-6) plasma levels after multiple trauma for the development of multi organ dysfunction syndrome(MODS) or sepsis. Technol Health Care, 2010, 18: 89- 100.

二级参考文献81

共引文献481

同被引文献151

  • 1张代民.降钙素原的测定与临床应用进展[J].实用医药杂志,2007,24(5):619-622. 被引量:57
  • 2邢志广,周伟强,沈琪琳,瘳卫,杨艳兵,禹磊.菌群失调患儿腹泻标本细菌学及pH值和球杆比变化的临床意义[J].中国妇幼保健,2007,22(32):4572-4574. 被引量:4
  • 3Agarwal S, Akbas N, Soundar E P, et al. Validation of the procalcitanin (PCT) assay: Experience in a pediatric hospital[J]. Clin Biochem, 2015, 48( 13/14): 886.
  • 4Hattori T, Nishiyama H, Kato H, et al. Clinical value of proealcitonin for patients with suspected bloodstream infection[J]. Am J Clin Pathol, 2014, 141( 1 ): 43.
  • 5Wang H, Yin F, Shen D X, et al. Predictive value of proealcitonin for excluding bloodstream infection: results of a retrospective study and utility of a rapid, quantitative test for procalcitonin[J]. J Int Med Res, 2013, 41(5): 1671.
  • 6Charles P E, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria[J]. BMC Infect Dis, 2008, 8( 1 ): 1.
  • 7Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and management of sepsis[J]. Diagn Microbiol Infect Dis, 2012, 73 (3): 221.
  • 8Elson G, Dunn-Siegrist I, Daubeuf B, et al. Contribution of toll-like receptors to the innate immune response to gram-negative and gram-positive bacteria[J]. Blood, 2007, 109(4): 1574.
  • 9Ferwerda B, Alonso S, Banahan K, et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock[J]. Proc Natl Acad Sci U S A, 2009, 106(25 ): 10272.
  • 10Hall K K, Lyman J A. Updated review of blood culture contamination[J]. Clin Microbiol Rev, 2006,19(4): 788.

引证文献16

二级引证文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部